Trade Alert: Dietmar Hopp At CureVac N.V. (NASDAQ:CVAC), Has Just Spent €97m Buying 71% More Shares

By
Simply Wall St
Published
May 08, 2022
NasdaqGM:CVAC
Source: Shutterstock

Those following along with CureVac N.V. (NASDAQ:CVAC) will no doubt be intrigued by the recent purchase of shares by insider Dietmar Hopp, who spent a stonking US$97m on stock at an average price of US$16.97. That purchase boosted their holding by 71%, which makes us wonder if the move was inspired by quietly confident deeply-felt optimism.

Check out our latest analysis for CureVac

The Last 12 Months Of Insider Transactions At CureVac

In fact, the recent purchase by Dietmar Hopp was the biggest purchase of CureVac shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at above the current price of US$15.64. Their view may have changed since then, but at least it shows they felt optimistic at the time. To us, it's very important to consider the price insiders pay for shares. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. Dietmar Hopp was the only individual insider to buy shares in the last twelve months.

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
NasdaqGM:CVAC Insider Trading Volume May 8th 2022

CureVac is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Does CureVac Boast High Insider Ownership?

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. A high insider ownership often makes company leadership more mindful of shareholder interests. CureVac insiders own 9.1% of the company, currently worth about US$266m based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

So What Does This Data Suggest About CureVac Insiders?

The recent insider purchase is heartening. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making losses. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about CureVac. Looks promising! So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. To assist with this, we've discovered 2 warning signs that you should run your eye over to get a better picture of CureVac.

Of course CureVac may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Discounted cash flow calculation for every stock

Simply Wall St does a detailed discounted cash flow calculation every 6 hours for every stock on the market, so if you want to find the intrinsic value of any company just search here. It’s FREE.

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.